Predictors of 30-day mortality in major lower limb amputations: insights from a five-year retrospective study in a South Asian LMIC

南亚低收入和中等收入国家一项为期五年的回顾性研究揭示了下肢大截肢术后30天死亡率的预测因素。

阅读:1

Abstract

BACKGROUND: Major lower limb amputation (MLLA) is a life-saving procedure with significant morbidity and mortality. The objectives of this study were to determine the incidence of 30-day mortality, perioperative complications, and predictive risk factors of mortality in MLLA patients. METHODS: This retrospective cohort study included patients undergoing MLLA at The Aga Khan University Hospital, Pakistan, from January 2018 to December 2022. Data was collected using chart reviews and analyzed via Stata 15. Demographic, clinical, and procedural variables were examined. Predictive factors for 30-day mortality were assessed using Firth logistic regression. RESULTS: Among 286 patients, the mean age was 49.4 ± 20.9 years, and 79.4% were male. The leading indications for MLLA were diabetic foot (43.4%) and trauma (23.8%). Thirty-day mortality was 6.6%. Most deaths occurred in patients with diabetic foot (68.4%), chronic kidney disease (31.6%), or ischemic heart disease (36.8%). Below-knee amputation accounted for 68.4% of cases. Postoperative infections (11.2%) and stump necrosis (4.2%) were the most common complications. Multivariable analysis identified chronic kidney disease (OR: 3.613; 95% CI: 1.112-11.739; p = 0.033) and postoperative local wound infection (OR: 3.416; 95% CI: 1.036-11.267; p = 0.044) as significant predictors of 30-day mortality in this cohort. CONCLUSION: MLLA is associated with considerable short-term mortality, particularly among patients with chronic kidney disease and postoperative surgical site infections. These findings emphasize the need for proactive identification of high-risk individuals, optimization of comorbid conditions, especially renal function, and strengthening perioperative infection control practices to improve patient outcomes in resource-limited settings.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。